3Rs Working Party (3RsWP) plenary meeting – Public session on the 2024 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 March 2024, 09:00 (CET) to 20 March 2024, 10:00 (CET)
Eight Nitrosamine Implementation Oversight Group (NIOG) meeting and Fifth Nitrosamine Implementation Oversight Group (NIOG) – meeting with pharmaceutical industry, European Medicines Agency, Amsterdam, the Netherlands, 7 September 2022
Training webinar on the use of Scientific Explorer in scientific advice regulatory procedures, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 April 2024, 11:30 (CEST) to 12 April 2024, 14:00 (CEST)
Quarterly System Demo Q1 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2024, 09:00 (CET) to 26 March 2024, 13:30 (CET)
The European Parliament’s vote on Strategic Technologies for Europe Platform (STEP) represents an important first move to ensure European industry remains competitive and innovative. EuropaBio welcomes the inclusion of biotech according to the OECD definition as a strategic technology for Europe. The post Biotech recognised in regulation for Europe’s future: EuropaBio welcomes European Parliament’s vote on Strategic Technologies forEurope Platform Regulation first appeared on Europabio.
EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 29 February 2024
SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)
Clinical Trials Information System Webinar: Last Year of Transition, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2024, 13:00 (CET) to 25 March 2024, 17:30 (CET)
Cancer Medicines Forum workshop: April 2024, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 April 2024, 13:00 (CEST) to 5 April 2024, 18:00 (CEST)
Cancer Medicines Forum workshop, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 April 2024, 13:00 (CEST) to 5 April 2024, 18:00 (CEST)
Paediatric Committee (PDCO): 20-23 February 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 February 2024 to 23 February 2024
Network users training for Regulatory Procedure Management 1st roll-out on IRIS, Online, from 16 January 2024, 10:00 (CET) to 16 January 2024, 12:00 (CET)
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 19 February 2024 to 22 February 2024
Objective: The global burden of HIV remains a critical public health challenge, particularly in sub-Saharan Africa, home to over two-thirds of individuals living with HIV. HIV self-testing (HIVST) has emerged as a promising strategy endorsed by the World Health Organization to achieve UNAIDS targets. Despite its potential, challenges persist in linking self-testers to care post a positive result. Digital health interventions, including chatbots and mobile applications, offer innovative solutions to address this gap. However, a comprehensive bibliometric analysis of the collaboration and growth in the literature at the intersection of HIVST and digital interventions is lacking.Methods: The study employs a bibliometric approach, leveraging data from the Web of Science, to analyze the characteristics, citation pattern and content of 289 articles spanning 1992–2023. The analysis involves performance assessment, scientific collaboration analysis, science mapping, and content analysis. Key bibliometric indicators, such as annual growth rate, citation impact, and authorship patterns, are explored. Collaboration patterns among countries, institutions, and authors are elucidated, and thematic mapping provides insight into the key research themes.Results: The analysis reveals a dynamic and expanding field, with an annual scientific growth rate of 12.25%. Notable contributions come from diverse sources, including North America, Europe, and Africa. High-impact journals such as JMIR mHealth and uHealth play a crucial role in disseminating research findings. African authors, including Lebelonyane R, Ford N, and Lockman S, feature prominently, reflecting a positive trend in diverse authorship. Co-citation analysis highlights influential manuscripts, with systematic reviews dominating the top-cited articles. Collaboration analysis underscores strategic partnerships globally, particularly involving the United States, Australia, South Africa, and the United Kingdom.Conclusion: This bibliometrics analysis provides a comprehensive overview of the digital health landscape in HIVST and linkage to care. It identifies key contributors, high-impact journals, and collaborative networks. The thematic map reveals nuanced research domains, including alcohol dependence, men’s health, outcomes, and user acceptance. The findings offer insights for researchers, policymakers, and practitioners, guiding future directions in the evolving intersection of HIVST and digital health interventions.
Multi-stakeholder webinar on the HMA-EMA Catalogues of real-world data sources and studies, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 March 2024, 10:00 (CET) to 4 March 2024, 12:00 (CET)
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meeting - April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 April 2024, 14:00 (CEST) to 12 April 2024, 16:00 (CEST)
Technical Webinar: Regulatory Procedure Management for PLM in IRIS for Network Users, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024, 14:00 (CET) to 27 February 2024, 16:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 March 2024, 10:00 (CET) to 19 March 2024, 12:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 March 2024, 10:00 (CET) to 19 March 2024, 12:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - February 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 February 2024, 10:00 (CET) to 20 February 2024, 12:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 February 2024, 10:00 (CET) to 20 February 2024, 12:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 May 2024, 10:00 (CEST) to 29 May 2024, 12:00 (CEST)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), European Medicines Agency, Amsterdam, the Netherlands, from 29 May 2024, 10:00 (CEST) to 29 May 2024, 12:00 (CEST)
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024 to 28 February 2024
Product Management Services (PMS) deep-dive webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 February 2024, 10:00 (CET) to 22 February 2024, 12:00 (CET)
Paediatric Committee (PDCO): 12-15 December 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 December 2023 to 15 December 2023
Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023
European Medicines Agency (EMA) and Federation of Veterinarians of Europe (FVE) info session on the UPD public portal, Online, from 21 February 2024, 15:00 (CET) to 21 February 2024, 16:30 (CET)
European Medicines Agency (EMA) and Federation of Veterinarians of Europe (FVE) info session on the UPD public portal, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 February 2024, 15:00 (CET) to 21 February 2024, 16:30 (CET)
Update webinar on Regulatory Procedure Management for Product Lifecycle Management on IRIS, Online, from 13 February 2024, 10:00 (CET) to 13 February 2024, 11:30 (CET)
Background: COVID-19-related global health governance (GHG) processes and public health measures taken influenced population health priorities worldwide. We investigated the intersection between COVID-19-related GHG and how it redefined population health priorities in Canada and other G20 countries. We analysed a Canada-related multilevel qualitative study and a scoping review of selected G20 countries. Findings show the importance of linking equity considerations to funding and accountability when responding to COVID-19. Nationalism and limited coordination among governance actors contributed to fragmented COVID-19 public health responses. COVID-19-related consequences were not systematically negative, but when they were, they affected more population groups living and working in conditions of vulnerability and marginalisation.Policy options and recommendations: Six policy options are proposed addressing upstream determinants of health, such as providing sufficient funding for equitable and accountable global and public health outcomes and implementing gender-focused policies to reduce COVID-19 response-related inequities and negative consequences downstream. Specific programmatic (e.g., assessing the needs of the community early) and research recommendations are also suggested to redress identified gaps.Conclusion: Despite the consequences of the COVID-19 pandemic, programmatic and research opportunities along with concrete policy options must be mobilised and implemented without further delay. We collectively share the duty to act upon global health justice.
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2024, European Medicines Agency, Amsterdam, the Netherlands, 29 January 2024
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), European Medicines Agency, Amsterdam, the Netherlands, 29 January 2024
Committee for Advanced Therapies (CAT): 6-8 December 2023, European Medicines Agency, Amsterdam, the Netherlands, from 6 December 2023 to 8 December 2023
Committee for Herbal Medicinal Products (HMPC): 29-31 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 29 January 2024 to 31 January 2024
ACT EU Training for non-commercial sponsors: Transitioning trials to the CTR (CTIS) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 February 2024, 10:00 (CET) to 9 February 2024, 13:00 (CET)
EMA Veterinary Medicines Info Day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 March 2024, 14:00 (CET) to 15 March 2024, 12:30 (CET)
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 January 2024, 10:00 (CET) to 22 January 2024, 13:30 (CET)
Multi-stakeholder workshop on Data Quality Framework for Adverse Drug Reaction reporting, Online, from 1 March 2024, 09:30 (CET) to 1 March 2024, 15:40 (CET)
EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma, Online, European Medicines Agency, Amsterdam, the Netherlands, 12 January 2024
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 22 January 2024 to 25 January 2024
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024 to 28 February 2024
Second European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Clinical Trials Information System (CTIS) sponsor end user training programme - February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 12 February 2024, 09:00 (CET) to 15 February 2024, 13:30 (CET)
Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 January 2024 to 18 January 2024
Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)
Eleventh meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, European Medicines Agency, Amsterdam, the Netherlands, 24 November 2023
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 14 February 2024, 10:00 (CET) to 14 February 2024, 13:30 (CET)
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 3 June 2024 to 7 June 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 13 May 2024 to 17 May 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 15 April 2024 to 19 April 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 4 March 2024 to 8 March 2024
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 10:00 (CET) to 23 November 2023, 12:00 (CET)
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 29 January 2024 to 2 February 2024
Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, Amsterdam, the Netherlands, 26 November 2018
ACT EU Clinical Trials Analytics Workshop - January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 25 January 2024, 13:00 (CET) to 26 January 2024, 13:00 (CET)
EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024 to 17 April 2024
ACT EU PA08 multi-stakeholder methodology workshop, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 09:00 (CET) to 23 November 2023, 17:00 (CET)
EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, European Medicines Agency, Amsterdam, the Netherlands, 29 February 2024
DARWIN EU Advisory Board meeting - 24 May 2023, European Medicines Agency, Amsterdam, the Netherlands, from 24 May 2023, 14:30 (CEST) to 24 May 2023, 16:30 (CEST)
Clinical Trials Information System (CTIS): Walk-in clinic - November 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 November 2023, 16:00 (CET) to 15 November 2023, 17:00 (CET)
Clinical Trials Information System (CTIS): Walk-in clinic - January 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 January 2024, 16:00 (CET) to 24 January 2024, 17:00 (CET)
DARWIN EU Advisory Board meeting: 6 February 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 February 2023, 10:00 (CET) to 6 February 2023, 12:00 (CET)
Clinical Trials Information System (CTIS): Walk-in clinic - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 March 2024, 16:00 (CET) to 12 March 2024, 17:00 (CET)
Webinar on the Union Product Database Data Quality Framework, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 January 2024, 15:00 (CET) to 11 January 2024, 16:30 (CET)
Committee for Medicinal Products for Human Use (CHMP): 11-14 December 2023, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2023 to 14 December 2023
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations, European Medicines Agency, Amsterdam, the Netherlands, 14 November 2023
EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma, Online, European Medicines Agency, Amsterdam, the Netherlands, 12 January 2024
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12 February 2024 to 13 February 2024
Product Lifecycle Management (PLM) Value Stream Deep-Dive Webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 November 2023, 14:00 (CET) to 30 November 2023, 16:00 (CET)
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 6 November 2023, 13:30 (CET) to 6 November 2023, 15:00 (CET)
Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023
Second bilateral meeting between European Medicines Agency (EMA) and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, from 27/11/2023 to 27/11/2023
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 19 September 2023
Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders , Online, 29 January 2024
Awareness session for SMEs on the reform of the EU pharmaceutical legislation, Online, European Medicines Agency, Amsterdam, the Netherlands, 24 November 2023
Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders, Online, from 29/01/2024 to 29/01/2024
18th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2023, 13:00 (CET) to 22 November 2023, 16:30 (CET)
EudraVigilance and Signal Management information day, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2023, 09:30 (CET) to 21 November 2023, 17:00 (CET)
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) AI workshop – Smart regulation in a rapidly evolving world, European Medicines Agency, Amsterdam, the Netherlands, 20 November 2023
Clinical Trials Information System (CTIS) bitesize talk: Training materials, CTIS pre-requisites, and updates on transparency rules, Online, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Clinical Trials Information System (CTIS) bitesize talk: Training materials, CTIS pre-requisites, and updates on transparency rules, Online, 15:30, from 29/11/2023 to 29/11/2023
The European Commission has launched a call for expressions of interest to represent patients’ organisations in EMA's Committee for Orphan Medicinal...
Focus group on veterinary pharmacovigilance reporting in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023
Focus group meeting for veterinarians or other healthcare professionals on facilitating pharmacovigilance reporting of medicinal products used in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023
Workshop on generating clinical evidence for treatment and prevention options for long-COVID and post-acute sequelae condition (PASC), Online, 13:00 - 18:00 Amsterdam time (CET), from 17/11/2023 to 17/11/2023
Awareness session for SMEs on the reform of the EU pharmaceutical legislation, Online, 10:00 – 12:00 (Amsterdam time CET), from 24/11/2023 to 24/11/2023
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 06/11/2023 to 06/11/2023
Committee for Medicinal Products for Veterinary Use (CVMP): 3-5 October 2023, European Medicines Agency, Amsterdam, the Netherlands, from 03/10/2023 to 05/10/2023
Meeting of the CTTI/FDA Patient Engagement Collaborative (PEC) and EMA Patients and Consumers Working Party (PCWP), Online, from 20/07/2023 to 20/07/2023
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, 15:00 - 17:00 Amsterdam time (CEST), from 22/09/2023 to 22/09/2023
Joint EMA-ECDC press briefing on current state of respiratory diseases and treatments in the EU/EEA, Online, 14:30 – 15:00 Amsterdam time (CEST), from 21/09/2023 to 21/09/2023
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) AI workshop – Smart regulation on a rapidly evolving world, European Medicines Agency, Amsterdam, the Netherlands, from 20/11/2023 to 20/11/2023
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2023, European Medicines Agency, Amsterdam, the Netherlands, from 11/09/2023 to 14/09/2023
LinkedIn Live interview with Ivo Claassen: Tomorrow's veterinary medicines for healthy animals and humans, Online, 13:15-13:45 Amsterdam time (CEST), from 07/09/2023 to 07/09/2023
Twelfth Paediatric Oncology Strategy Forum for Medicinal Product Development of CDK4/6, CDK7 and CDK9 Inhibitors in children and adolescents, Hybrid, from 26/10/2023 to 27/10/2023
Clinical Trials Information System (CTIS) bitesize talk: Part I-only applications and Part II requirements in CTIS, Online, 15:30 - 17:00 Amsterdam time (CEST), from 30/08/2023 to 30/08/2023
Union Product Database – Product grouping and 3rd country product names Webinar for UPD Industry users, Online, 14:00 –15:00 Amsterdam time (CEST), from 18/09/2023 to 18/09/2023
European Medicines Agency / Emergency Task Force and European Commission workshop on lessons learned on clinical trials in public health emergencies, from 25/07/2023 to 25/07/2023
Second European Medicines Agency & MedTech Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2023 to 11/04/2023
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, 13:00 - 14:00 Amsterdam time (CEST), from 14/07/2023 to 14/07/2023
Multi-stakeholder workshop on Real World Data (RWD) quality and Real World Evidence (RWE) use, European Medicines Agency and online, from 26/06/2023 to 27/06/2023
SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, from 12/10/2023 to 12/10/2023
Meeting of the Executive Steering Group on Shortages of Medical Devices (MDSSG), Online, 15:30 - 16:30 Amsterdam time (CEST), from 19/06/2023 to 19/06/2023
EudraVigilance and Signal Management information day, European Medicines Agency, Amsterdam, the Netherlands, 09:30-17:00 CET, from 21/11/2023 to 21/11/2023
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system, Online, 14:00 - 18:00 Amsterdam time CEST , from 27/11/2023 to 29/11/2023
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system, Online, 09:00 - 13:00 Amsterdam time CEST , from 04/10/2023 to 06/10/2023
Human variations electronic Application Form (eAF) & Product Management Service (PMS) Q&A clinics - Session 1, Online, 15:00 - 15:30 Amsterdam time (CET), from 15/06/2023 to 15/06/2023
Human variations electronic Application Form (eAF) & Product Management Service (PMS) Q&A clinics - Session 2, Online, 15:00 - 15:30 Amsterdam time (CET), from 22/06/2023 to 22/06/2023
Tenth meeting the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, 09:30 - 13:30 Amsterdam time (CET), from 27/06/2023 to 27/06/2023
Clinical Trials Information System (CTIS) sponsor end user training programme - December 2023, Online, 09:00 - 13:30 Amsterdam time (CET), from 11/12/2023 to 14/12/2023
Clinical Trials Information System (CTIS) sponsor end user training programme - November 2023, Online, 14:00 - 18:30 Amsterdam time (CET), from 06/11/2023 to 09/11/2023
Clinical Trials Information System (CTIS) sponsor end user training programme - September 2023, Online, 09:00 - 13:30 Amsterdam time (CET), from 19/09/2023 to 22/09/2023
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course on using the EudraVigilance system, Online, from 04/12/2023 to 08/12/2023
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course on using the EudraVigilance system, Online, from 23/10/2023 to 27/10/2023
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course on using the EudraVigilance system, Online, from 13/11/2023 to 17/11/2023
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course on using the EudraVigilance system, Online, from 25/09/2023 to 29/09/2023